Provided by Tiger Trade Technology Pte. Ltd.

Belite Bio, Inc.

169.44
-3.5600-2.06%
Volume:151.85K
Turnover:25.82M
Market Cap:6.82B
PE:-61.88
High:173.01
Open:173.00
Low:168.40
Close:173.00
52wk High:200.00
52wk Low:64.80
Shares:40.27M
Float Shares:19.55M
Volume Ratio:0.56
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7382
EPS(LYR):-2.3141
ROE:-22.10%
ROA:-15.65%
PB:8.79
PE(LYR):-73.22

Loading ...

Belite Bio Price Target Maintained With a $200.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 15

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Rhythm Pharmaceuticals (RYTM) and Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Jun 15

Belite Bio completes rolling submission of NDA to U.S. FDA for tinlarebant

TIPRANKS
·
Jun 15

Belite Bio completes rolling FDA NDA submission for tinlarebant in Stargardt disease type 1

Reuters
·
Jun 13

Belite Bio - Application to Undergo 60-Day FDA Review; Pdufa Date to Be Assigned IF Accepted

THOMSON REUTERS
·
Jun 13

Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1

THOMSON REUTERS
·
Jun 13

A Look At Belite Bio (BLTE) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Jun 08

Belite Bio to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

GlobeNewswire
·
Jun 02

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 28

Will Widening Losses and Renewed Buy Ratings Change Belite Bio's (BLTE) Narrative?

Simply Wall St.
·
May 28

Belite Bio Inc : Mizuho Cuts Target Price to $215 From $223

THOMSON REUTERS
·
May 26

Mizuho Securities Remains a Buy on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
May 26

U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy

Reuters
·
May 26

Belite Bio Price Target Maintained With a $200.00/Share by HC Wainwright & Co.

Dow Jones
·
May 21

Stock Track | Belite Bio Soars 5.27% Intraday on NDA Submission Progress and Strong Analyst Backing

Stock Track
·
May 20

Belite Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 20

Belite Bio Q1 Adjusted Loss Widens

MT Newswires Live
·
May 20

Belite Bio Q1 EPS $(0.45) Beats $(0.63) Estimate

Benzinga Earnings
·
May 20

Belite Bio Q1 FY26 net loss widens to $26.94 million

Reuters
·
May 20

BRIEF-Belite Bio Q1 Net Income USD -26.938 Million

Reuters
·
May 20